Otoacoustic emissions for outcome prediction in postanoxic brain injury by Kondziella, Daniel et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Otoacoustic emissions for outcome prediction in postanoxic brain injury
Kondziella, Daniel; Jensen, Anne Marie; Hjuler, Thomas; Bille, Michael; Kjaergaard, Jesper
Published in:
Frontiers in Neurology
DOI:
10.3389/fneur.2018.00796
Publication date:
2018
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Kondziella, D., Jensen, A. M., Hjuler, T., Bille, M., & Kjaergaard, J. (2018). Otoacoustic emissions for outcome
prediction in postanoxic brain injury. Frontiers in Neurology, 9(SEP), [796].
https://doi.org/10.3389/fneur.2018.00796
Download date: 03. Feb. 2020
BRIEF RESEARCH REPORT
published: 25 September 2018
doi: 10.3389/fneur.2018.00796
Frontiers in Neurology | www.frontiersin.org 1 September 2018 | Volume 9 | Article 796
Edited by:
Wengui Yu,
University of California, Irvine,
United States
Reviewed by:
Benjamin Aaron Emanuel,
University of Southern California,
United States
Cyrus Khurshed Dastur,
University of California, Irvine,
United States
*Correspondence:
Daniel Kondziella
daniel_kondziella@yahoo.com
Specialty section:
This article was submitted to
Neurocritical and Neurohospitalist
Care,
a section of the journal
Frontiers in Neurology
Received: 21 July 2018
Accepted: 04 September 2018
Published: 25 September 2018
Citation:
Kondziella D, Jensen AM, Hjuler T,
Bille M and Kjaergaard J (2018)
Otoacoustic Emissions for Outcome
Prediction in Postanoxic Brain Injury.
Front. Neurol. 9:796.
doi: 10.3389/fneur.2018.00796
Otoacoustic Emissions for Outcome
Prediction in Postanoxic Brain Injury
Daniel Kondziella 1*, Anne Marie Jensen 2, Thomas Hjuler 2, Michael Bille 2 and
Jesper Kjaergaard 3
1Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, 2Department of
Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen,
Denmark, 3Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Background: Non-invasive, easy-to-use bedside tools to estimate prognosis in
unresponsive patients with postanoxic brain injury are needed. We assessed the
usefulness of otoacoustic emissions as outcome markers after cardiac arrest.
Methods: Distortion product otoacoustic emissions (DPOAE) and transient evoked
otoacoustic emissions (TEOAE) were measured in cardiac arrest patients whose
prognosis was deemed to be poor following standard neurological assessment (n = 10).
Ten patients with myocardial infarction without prior loss of consciousness served as
controls.
Results: Compared to controls with myocardial infarction, cardiac arrest patients with
poor neurological prognosis had significantly less often preserved DPOAE (9.2 vs. 40.8%
positive measurements; OR 0.15 (CI 0.07–0.30); p< 0.0001). Partially preserved DPOAE
were noted in 4 cardiac arrest patients. TEOAE were not statistically different between
the two groups.
Conclusions: Despite their convenience, otoacoustic emissions cannot be used as
reliable prognostic markers in cardiac arrest survivors. This is because we identified 4
cases with partially preserved otoacoustic emissions in a sample of 10 unresponsive
post-cardiac arrest patients whose neurological condition was so poor that active
treatment was withdrawn. However, we suggest that future research should address
if decaying outer hair cell function over time may serve as a proxy for evolving ischemic
brain damage.
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INTRODUCTION
Otoacoustic emissions are small sounds generated by the outer hair cell activity in the cochlear
and can be measured in the ear canal of healthy people. These sounds are by-products of active
processes in the cochlea, in which motility of the outer hair cells adjusts the basilar membrane
and amplifies weak sounds. Although they do not contribute to hearing, otoacoustic emissions are
clinically important because they allow evaluation of the integrity of outer hair cell function and
the cochlea. They are therefore routinely assessed for evaluation of hearing, including screening in
newborns.
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A pre-neuronal phenomenon, otoacoustic emissions are
unaffected by sedation; they can be assessed non-invasively at
the bedside using an automated hand-held device; costs are low;
and analysis does not require elaborate data post-processing
(Figure 1) (1, 2). These are all features of a convenient candidate
biomarker for prognostication following anoxic brain injury.
However, the usefulness of otoacoustic emissions as prognostic
markers after cardiac arrest is unknown.
The intention of this exploratory study was to compare
otoacoustic emissions in patients from the extreme sides of the
clinical spectrum, that is, cardiac arrest with poor neurological
prognosis (fatal cerebral anoxic-ischemic injury) on one side and
myocardial infarction without loss of consciousness on the other
(no cerebral anoxic-ischemic injury).
We hypothesized that otoacoustic emissions would be
absent in comatose cardiac arrest patients with irreversible
anoxic-ischemic encephalopathy but relatively preserved in
neurologically normal patients with myocardial infarctions and
without prior loss of consciousness.
METHODS
We assessed distortion product otoacoustic emissions (DPOAE)
and transient evoked otoacoustic emissions (TEOAE) in both
ears of 10 consecutive unresponsive cardiac arrest survivors
in whom a decision had been made to withdraw treatment
based on standardized neurological assessment, including
neuroimaging, electroencephalography, median nerve sensory
FIGURE 1 | This figure shows a screenshot depicting a schematic overview of distortion product otoacoustic emissions (DPOAE) of the right ear of a healthy
volunteer. DPOAE were present at 1, 2, 3, 4, and 6 kHz (but not 1.5 kHz). Otoacoustic emissions were assessed with the OAE Titan (® Interacoustics, Middelfart,
Denmark), an automated handheld device. The procedure takes less than 2min. dB SPL – decibel sound pressure level; kHz −1,000 Hertz.
evoked potentials, and serum biomarkers, ≥ 72 h after target
temperature management and tapering of sedation. DPOAE and
TEOAE, as well as auditory brainstem response audiometry, were
assessed within 3 h prior to extubation and palliation. Ten age-
and sex-matched patients with myocardial infarction without
prior loss of consciousness served as controls.
Otoscopy and tympanometry was performed prior to testing
of otoacoustic emissions in order to exclude obstruction of
the ear canal and middle-ear effusion. Otoacoustic emissions
were assessed using OAE Titan ( R©Interacoustics, Middelfart,
Denmark) and TEOAE were recorded using AccuScreen
( R©Otometrics, Taastrup, Denmark), as described earlier (1).
Briefly, a sensitive, low noise microphone is sealed in the external
ear canal and an acoustic stimulus is delivered. The sound in
the external ear canal that is elicited in response to the acoustic
stimulus is recorded by the microphone (Figure 1).
Odds ratios were calculated and the level of statistical
significance was set to p < 0.01. The Ethics Committee of the
Capital Region of Denmark (De Videnskabsetiske Kommiteer—
Region Hovedstaden, Hillerød, Denmark) approved the study
and waived the need for written consent because risks were
deemed negligible (reference j.nr. H-17038640).
RESULTS
Following cardiac arrest with severe anoxic-ischemic brain
injury, TEOAE were present in 2 out of 20 measurements (i.e., 2
out of 10 cases; mean age 63.2± 12.6 years; 2 females). Following
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TABLE 1A | Contingency table showing the frequency of present vs. absent
distortion product otoacoustic emissions (DPOAE) in patients following cardiac
arrest (cases), respectively, myocardial infarction without loss of consciousness
(controls).
DPOAE present DPOAE absent Total Percent
Cases
Post-cardiac arrest
patients (n = 10)
11 109 120 9.2%
Controls
Myocardial infarct
patients (n = 10)
49 71 120 40.8%
DPOAE were significantly less frequent after cardiac arrest (9.2 vs. 40.8%; OR 0.15 (CI
0.07–0.30); p < 0.0001).
TABLE 1B | Summary of individual results from cardiac arrest patients (cases) and
patients with myocardial infarction but normal consciousness (controls).
Preserved responses
after cardiac arrest
(n = 10 cases)
Preserved responses
after myocardial
infarction (n = 10
controls)
Auditory brainstem
response audiometry
45 dB nHL
1r,l; 2l 3r,l; 5r,l; 6r,l; 7r,l; 8r,l;
10r,l
TEOAE 1r; 5l 2r,l; 3l,r; 6r,l; 8r; 10r,l
DPOAE 1 kHz 6l 2l; 5l,r; 7r; 8r; 10r,l
DPOAE 1.5 kHz 1r; 5l; 6l 2r,l; 3r,l; 5r,l; 6r,l; 8r,l; 9r;
10r,l
DPOAE 2 kHz 1r, 6l, 7r 2r; 3r,l; 4r; 5r; 6l,r; 8r,l;
9r; 10r,l
DPOAE 3 kHz 1r, l 3r,l; 6r; 7r,l; 8r,l; 9r;10r,l
DPOAE 4 kHz 1r; 6r 3r,l; 4r; 7r,l; 8r; 9r
DPOAE 6 kHz
Only preserved responses are listed. Auditory brainstem responses could not be acquired
in 3 controls due to excessive facial hair growth (patient 4), signal loss for technical reasons
(patient 2), and complaints of lightheadedness (patient 9), respectively. DPOAE, distortion
product otoacoustic emissions; l, left ear; r, right ear; TEOAE, transient evoked otoacoustic
emissions; numbers denote individual patients. dB nHL, decibel normalized hearing level.
myocardial infarction without loss of consciousness, TEOAE
were noticed in 9/20measurements (5/10 controls; mean age 66.5
± 8.3 years; 2 females).
DPOAE (which are frequency-specific) were present in 11/120
measurements after cardiac arrest (4/10 cases) and in 49/120
measurements following myocardial infarction (9/10 controls).
Compared to myocardial infarct patients with preserved
consciousness, cardiac arrest patients had significantly less often
preserved DPOAE [9.2 vs. 40.8%; OR 0.15 (CI 0.07–0.30); z
statistic 5.24; p < 0.0001)].
Table 1 provides further details.
DISCUSSION
Outcome prognostication following cardiac arrest is essential,
yet challenging (3). EEG is valuable but affected by levels
of sedation and requires neurophysiological expertise (4, 5).
Similarly, magnetic resonance imaging is promising but is
associated with significant logistical challenges in the intensive
care setting (6). Finally, new biomarkers such as serum tau appear
to have good sensitivity and specificity but need further validation
(7). A cheap point-of-care test that is easily interpretable,
universally available and unaffected by sedation is clearly
needed.
Otoacoustic emissions fulfill all criteria mentioned (1, 2)
but previous studies have only assessed their role in perinatal
anoxic-ischemic injury (8–10) and intracranial hypertension
(11–13). Our study is the first to assess the potential of
otoacoustic emissions for prognostication of adult cardiac arrest
survivors. However, we conclude that otoacoustic emissions do
not represent reliable outcome markers for neurological recovery
after cardiac arrest because we identified 4 cases with (partially)
preserved otoacoustic emissions in a sample of 10 unresponsive
post-cardiac arrest patients whose neurological condition was
so poor that active treatment was withdrawn (cases 1, 5-7;
Table 1b).
While isolated measurements do not appear to add crucial
information at the single-subject level, our results indicate,
however, that otoacoustic emissions (i.e., DPOAE) are still
affected by global anoxia following cardiac arrest (p < 0.0001).
Thus, their usefulness as part of a multimodal approach,
including serial measurements, should be further investigated.
Decaying outer hair cell function over time may serve as a proxy
for evolving ischemic brain damage.
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